NCT04926922View on ClinicalTrials.gov

PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

June 7, 2026

Study Completion Date

June 7, 2026

Conditions
TuberculosisHIV
Trial Locations (5)

20892

National Institutes of Health Cinical Center, Bethesda

Unknown

C.H. Rennie Hospital, Kakata

Duport Road Clinic, Monrovia

JFK Medical Center, Monrovia

Redemption Hospital, Monrovia

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH